Company page
Kuros Biosciences Ltd.
Kuros Biosciences Ltd. is a public company listed under the ticker KURN on the Swiss market. The company has a market capitalization of approximately 919.45 million Swiss francs. Kuros Biosciences focuses on developing innovative therapies in the field of regenerative medicine.
- Ticker
- KURN:SIX
- Asset type
- Stock
- Market cap
- $919.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- SIX
- Currency
- CHF